IntelliQuit combines technologic sophistication and clinical insight to engage the world's 1.3 billion smokers and offers proven success.
NEW YORK, Oct. 22, 2014 /PRNewswire/ — National Respiratory Care Week in October is sponsored by the American Association of Respiratory Care, American Thoracic Society, the American College of Chest Physicians and the American Society of Anesthesiologists. Its primary care mission is to promote lung health and smoking is responsible for over 80% of all preventable lung disease and 90% of all lung cancer.
IntelliQuit, the world's first personal pocket size biosensor and ecosystem that biochemically measures tobacco consumption to help smokers stop is now available on-line via Kickstarter for $79 while supplies last. Similar to a breath alcohol meter, IntelliQuit provides the smoker actionable information to help the smoker quit. A drinker may remember how many drinks they consumed, they may know they are intoxicated, but they don't know their blood alcohol levels or when it is safe to drive. Similarly, IntelliQuit allows the smoker to quantify their smoking biochemically with a simple expired breath and offers a fuller understanding of tobacco consumption and addiction. Simply counting cigarettes (while IntelliQuit does that too) is not enough.
The long recognized phenomena of "compensatory smoking" means the nicotine consumed from every cigarette for every smoker can vary tremendously1. For example, taking more puffs per cigarettes, inhaling deeper and faster, holding smoke in the lungs longer can double or triple nicotine consumption. This knowledge can engage more smokers and has demonstrated increased quit rates, helping smokers stop. IntelliQuit works with e-cigarettes, prescription and OTC stop smoking medications, cold turkey or even smokers who are not ready to quit.
While an average of more than 65,000 Americans attempt to quit smoking each day, less than 6% are successful without assistance. "The IntelliQuit biosensor and ecosystem will provide information that has proven to assist quitting efforts. IntelliQuit is a superior product to empower America's 46 million smokers. You can stop, IntelliQuit will help," said Victor Marchione, MD FCCP, IntelliQuit's Chief Medical Officer.
"Not only have we produced a product and experience that works, it's also fun. After completion of this campaign, supporters can receive rewards that include our 'Crushin' Cigarettes and 'Smoke the Zombies' mobile games. University studies have shown our Crushin' Cigarettes game reduces smoking and increases quit rates 300 percent by increasing motivation and learning2. IntelliQuit also makes a great gift for smoking friends and family," said IntelliQuit's CEO Matthew Bars, MS CTTS.
The IntelliQuit biosensor, mobile app and related products are available at: www.kickstarter.com/projects/270050630/intelliquit-worlds-1st-smoking-biosensor-and-mobil.
Mr. Bars and Dr. Marchione have been treating smokers for a combined six decades. Matt is also the Director of the Tobacco Treatment Program of the New York City Fire Department and is a board certified tobacco treatment specialist. Since September 11, 2001 smoking prevalence has been reduced over 70 percent in the New York City Fire Department3. Victor is board certified in both pulmonary and internal medicine. "We have taken the lessons learnt at FDNY and working with smokers over the last 3 decades in helping tens of thousands quit and leveraged this knowledge with the power of mobile health and smart phone technology. We are not alone in believing that IntelliQuit will be a game changer in helping the world's more than one billion smokers. Smokers are literally dying to quit, IntelliQuit can help," Dr. Marchione concluded. Both Victor and Matt are also IntelliQuit co-founders. In March, IntelliQuit won first place at the TechCrunch NYC Pitch-Off.
For further information about IntelliQuit please visit www.MyLungTest.com
3Aldrich TK, Gustave J, Hall CB, et al. Lung Function in Rescue Workers at the World Trade Center after 7 Years. New England Journal of Medicine 2010; 362:1263 1272 http://www.nejm.org/doi/full/10.1056/NEJMoa0910087
Contact: Tracy Miceli
M (201) 214-3776
Email
